{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T15:34:49Z","timestamp":1761233689040,"version":"build-2065373602"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,23]]},"DOI":"10.7759\/cureus.95228","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T15:30:57Z","timestamp":1761233457000},"source":"Crossref","is-referenced-by-count":0,"title":["Occult Hypercalcemia Unmasked: Insights From Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Syndrome Associated With a Gastrointestinal Lymphoma"],"prefix":"10.7759","author":[{"given":"Zhihan","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Rui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1985.03360190069027","article-title":"Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome","volume":"254","author":"McCarty DJ","year":"1985","unstructured":"McCarty DJ, O'Duffy JD, Pearson L, Hunter JB. Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA. 1985, 254:2763-7.","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14423\/SMJ.0000000000001679","article-title":"Common comorbidities in patients with remitting seronegative and symmetrical synovitis with pitting edema (RS3PE)","volume":"117","author":"Esmaeilzadeh E","year":"2024","unstructured":"Esmaeilzadeh E, Morris CR. Common comorbidities in patients with remitting seronegative and symmetrical synovitis with pitting edema (RS3PE). South Med J. 2024, 117:241-4. 10.14423\/SMJ.0000000000001679","journal-title":"South Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.26574\/maedica.2023.18.1.143","article-title":"Atypical remitting seronegative symmetrical synovitis with pitting edema syndrome in an elderly lung cancer patient","volume":"18","author":"Ohara G","year":"2023","unstructured":"Ohara G, Uchiyama M, Sakurai H, Saito S, Hayashi S, Satoh H. Atypical remitting seronegative symmetrical synovitis with pitting edema syndrome in an elderly lung cancer patient. Maedica (Bucur). 2023, 18:143-7. 10.26574\/maedica.2023.18.1.143","journal-title":"Maedica (Bucur)"},{"key":"ref4","article-title":"RS3PE revisited: a systematic review and meta-analysis of 331 cases","volume":"34","author":"Karmacharya P","year":"2016","unstructured":"Karmacharya P, Donato AA, Aryal MR, et al.. RS3PE revisited: a systematic review and meta-analysis of 331 cases. Clin Exp Rheumatol. 2016, 34:404-15.","journal-title":"Clin Exp Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.7330","article-title":"Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome with underlying history of malignancy","volume":"11","author":"Kim K","year":"2023","unstructured":"Kim K, Marvil C, Adhyaru BB. Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome with underlying history of malignancy. Clin Case Rep. 2023, 11:e7330. 10.1002\/ccr3.7330","journal-title":"Clin Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.11.006","article-title":"Is remitting seronegative symmetrical synovitis with pitting edema (RS3PE) a subset of rheumatoid arthritis?","volume":"40","author":"Yao Q","year":"2010","unstructured":"Yao Q, Su X, Altman RD. Is remitting seronegative symmetrical synovitis with pitting edema (RS3PE) a subset of rheumatoid arthritis?. Semin Arthritis Rheum. 2010, 40:89-94. 10.1016\/j.semarthrit.2008.11.006","journal-title":"Semin Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2017.05.026","article-title":"Limitations in the use of 18F-FDG PET in the pre-operative staging of gastric cancer: a case series","volume":"36","author":"Fonocho E","year":"2017","unstructured":"Fonocho E, Aydin N, Reddy S, Misra S. Limitations in the use of 18F-FDG PET in the pre-operative staging of gastric cancer: a case series. Int J Surg Case Rep. 2017, 36:147-50. 10.1016\/j.ijscr.2017.05.026","journal-title":"Int J Surg Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary hyperparathyroidism","volume":"379","author":"Insogna KL","year":"2018","unstructured":"Insogna KL. Primary hyperparathyroidism. N Engl J Med. 2018, 379:1050-9. 10.1056\/NEJMcp1714213","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz278","article-title":"Calcitriol elevation is associated with a higher risk of refractory hypercalcemia of malignancy in solid tumors","volume":"105","author":"Chukir T","year":"2020","unstructured":"Chukir T, Liu Y, Hoffman K, Bilezikian JP, Farooki A. Calcitriol elevation is associated with a higher risk of refractory hypercalcemia of malignancy in solid tumors. J Clin Endocrinol Metab. 2020, 105:e1115-23. 10.1210\/clinem\/dgz278","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/1947-2714.170600","article-title":"Hypercalcemia of malignancy: an update on pathogenesis and management","volume":"7","author":"Mirrakhimov AE","year":"2015","unstructured":"Mirrakhimov AE. Hypercalcemia of malignancy: an update on pathogenesis and management. N Am J Med Sci. 2015, 7:483-93. 10.4103\/1947-2714.170600","journal-title":"N Am J Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S83681","article-title":"Hypercalcemia of malignancy and new treatment options","volume":"11","author":"Sternlicht H","year":"2015","unstructured":"Sternlicht H, Glezerman IG. Hypercalcemia of malignancy and new treatment options. Ther Clin Risk Manag. 2015, 11:1779-88. 10.2147\/TCRM.S83681","journal-title":"Ther Clin Risk Manag"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa391","article-title":"Role of the HPA axis in the metabolic and baroreflex components of hypoglycemia-associated autonomic failure","volume":"105","author":"Dagogo-Jack S","year":"2020","unstructured":"Dagogo-Jack S. Role of the HPA axis in the metabolic and baroreflex components of hypoglycemia-associated autonomic failure. J Clin Endocrinol Metab. 2020, 105:e3466-8. 10.1210\/clinem\/dgaa391","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-03007-8","article-title":"A case of hypercalcemia from Pneumocystis jirovecii in an immunosuppressed non-HIV patient","volume":"24","author":"Gulhati V","year":"2024","unstructured":"Gulhati V, Desy J, Thornton CS. A case of hypercalcemia from Pneumocystis jirovecii in an immunosuppressed non-HIV patient. BMC Pulm Med. 2024, 24:204. 10.1186\/s12890-024-03007-8","journal-title":"BMC Pulm Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13184","article-title":"Pneumocystis jirovecii pneumonia in diffuse large B-cell lymphoma treated with R-CHOP","volume":"64","author":"Lee JY","year":"2021","unstructured":"Lee JY, Kang M, Suh KJ, et al.. Pneumocystis jirovecii pneumonia in diffuse large B-cell lymphoma treated with R-CHOP. Mycoses. 2021, 64:60-5. 10.1111\/myc.13184","journal-title":"Mycoses"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042806","article-title":"Hypercalcemia associated with cancer","volume":"352","author":"Stewart AF","year":"2005","unstructured":"Stewart AF. Hypercalcemia associated with cancer. N Engl J Med. 2005, 352:373-9. 10.1056\/NEJMcp042806","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2010.02.010","article-title":"Vitamin D and the immune system: new perspectives on an old theme","volume":"39","author":"Hewison M","year":"2010","unstructured":"Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am. 2010, 39:365-79. 10.1016\/j.ecl.2010.02.010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.3.579","article-title":"Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages","volume":"18","author":"Hewison M","year":"2003","unstructured":"Hewison M, Kantorovich V, Liker HR, Van Herle AJ, Cohan P, Zehnder D, Adams JS. Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res. 2003, 18:579-82. 10.1359\/jbmr.2003.18.3.579","journal-title":"J Bone Miner Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155553","article-title":"Commentary on the Endocrine Society clinical practice guideline on the \"treatment of hypercalcemia of malignancy in adults\"","volume":"143","author":"El-Hajj Fuleihan G","year":"2023","unstructured":"El-Hajj Fuleihan G, Drake MT. Commentary on the Endocrine Society clinical practice guideline on the \"treatment of hypercalcemia of malignancy in adults\". Metabolism. 2023, 143:155553. 10.1016\/j.metabol.2023.155553","journal-title":"Metabolism"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1039490","article-title":"Cancer-related hypercalcemia and potential treatments","volume":"14","author":"Almuradova E","year":"2023","unstructured":"Almuradova E, Cicin I. Cancer-related hypercalcemia and potential treatments. Front Endocrinol (Lausanne). 2023, 14:1039490. 10.3389\/fendo.2023.1039490","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/406891-occult-hypercalcemia-unmasked-insights-from-remitting-seronegative-symmetrical-synovitis-with-pitting-edema-rs3pe-syndrome-associated-with-a-gastrointestinal-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T15:30:58Z","timestamp":1761233458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/406891-occult-hypercalcemia-unmasked-insights-from-remitting-seronegative-symmetrical-synovitis-with-pitting-edema-rs3pe-syndrome-associated-with-a-gastrointestinal-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.95228","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}